ID

12943

Descripción

Genetic Markers in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00014079

Link

https://clinicaltrials.gov/show/NCT00014079

Palabras clave

Versiones (1)
  1. 7/1/16 7/1/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

7 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Cancer NCT00014079

Inglés

Eligibility Colorectal Cancer NCT00014079

1 formularios  
Criteria
Descripción

Criteria

must have had a resectable adenocarcinoma of the colon or rectum and must have participated in one of the following ncctg randomized clinical trials:
Descripción

adenocarcinoma of the colon

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0699790
784852: no treatment control versus levamisole versus levamisole plus fluorouracil (5-fu)
Descripción

784852

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023556
UMLS CUI [2]
C0016360
794604: no treatment control versus 5-fu by portal vein infusion
Descripción

794604

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0016360
794751: postoperative radiation versus postoperative radiation plus sequential chemotherapy with methyl ccnu and 5-fu
Descripción

794751

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0023972
UMLS CUI [3]
C0016360
844652: an intergroup study - an evaluation of levamisole plus 5-fu as surgical adjuvant treatment for resectable adenocarcinoma of the colon
Descripción

844652

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023556
UMLS CUI [2]
C0016360
864751: phase iii protocol for surgical adjuvant therapy of rectal carcinoma: a controller evaluation of (a) protracted-infusion 5-fu as a radiation enhancer and (b) 5-fu plus methyl-ccnu chemotherapy
Descripción

864751

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C0016360
UMLS CUI [3]
C0023972
874651: m/n - a controller evaluation of recombinant interferon-gamma (ifl gm) and 5-fu and folinic acid with or without levamisole as adjuvant treatment for resectable adenocarcinoma of the colon
Descripción

874651

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2757040
UMLS CUI [2]
C0016360
UMLS CUI [3]
C0016410
UMLS CUI [4]
C0023556
894651: a controller phase iii evaluation of 5-fu combined with levamisole and leucovorin as adjuvant treatment for resectable colon cancer
Descripción

894651

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0016360
UMLS CUI [2]
C0023556
UMLS CUI [3]
C0023413
tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office
Descripción

tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040300
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Cancer NCT00014079

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
adenocarcinoma of the colon
Item
must have had a resectable adenocarcinoma of the colon or rectum and must have participated in one of the following ncctg randomized clinical trials:
boolean
C0699790 (UMLS CUI [1])
784852
Item
784852: no treatment control versus levamisole versus levamisole plus fluorouracil (5-fu)
boolean
C0023556 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
794604
Item
794604: no treatment control versus 5-fu by portal vein infusion
boolean
C0016360 (UMLS CUI [1])
794751
Item
794751: postoperative radiation versus postoperative radiation plus sequential chemotherapy with methyl ccnu and 5-fu
boolean
C1522449 (UMLS CUI [1])
C0023972 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
844652
Item
844652: an intergroup study - an evaluation of levamisole plus 5-fu as surgical adjuvant treatment for resectable adenocarcinoma of the colon
boolean
C0023556 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
864751
Item
864751: phase iii protocol for surgical adjuvant therapy of rectal carcinoma: a controller evaluation of (a) protracted-infusion 5-fu as a radiation enhancer and (b) 5-fu plus methyl-ccnu chemotherapy
boolean
C0543467 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0023972 (UMLS CUI [3])
874651
Item
874651: m/n - a controller evaluation of recombinant interferon-gamma (ifl gm) and 5-fu and folinic acid with or without levamisole as adjuvant treatment for resectable adenocarcinoma of the colon
boolean
C2757040 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0016410 (UMLS CUI [3])
C0023556 (UMLS CUI [4])
894651
Item
894651: a controller phase iii evaluation of 5-fu combined with levamisole and leucovorin as adjuvant treatment for resectable colon cancer
boolean
C0016360 (UMLS CUI [1])
C0023556 (UMLS CUI [2])
C0023413 (UMLS CUI [3])
tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office
Item
tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office
boolean
C0040300 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial